BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anondita Medicare IPO is Open!
Apply for the Anondita Medicare IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

524748

LINKPH

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

LINK PHARMA CHEM LTD. Share Price Update

As of the latest trading session, LINK PHARMA CHEM LTD. share price is currently at ₹ 35.89, which is down by ₹ -0.06 from its previous closing. Today, the stock has fluctuated between ₹ 34.26 and ₹ 35.89. Over the past year, LINK PHARMA CHEM LTD. has achieved a return of -18.71 %. In the last month alone, the return has been -1.82 %. Read More...

Investment Returns

Over 1 Month -1.82% Over 3 Months -3.18% Over 6 Months -4.92% Over 1 Year -18.71%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

LINK PHARMA CHEM LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    15.90

  • P/E Ratio (TTM)

    -17.28

  • Beta

    0.84

  • Book Value / share

    28.51

  • Return on equity

    -7.81%

  • EPS (TTM)

    0.00

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.40

info icon alternate text

LINK PHARMA CHEM LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 7.81
Operating Expense 7.51
Net Profit 0.40
Net Profit Margin (%) 5.12
Earnings Per Share (EPS) 0.91
EBITDA 0.85
Effective Tax Rate (%) 21.56
Particulars MAR 2025 (Values in Cr)
Revenue 6.45
Operating Expense 7.05
Net Profit -0.35
Net Profit Margin (%) -5.42
Earnings Per Share (EPS) -0.79
EBITDA -0.09
Effective Tax Rate (%) 27.08
Particulars DEC 2024 (Values in Cr)
Revenue 5.34
Operating Expense 5.68
Net Profit -0.67
Net Profit Margin (%) -12.54
Earnings Per Share (EPS) -1.50
EBITDA -0.44
Effective Tax Rate (%) 24.71
Particulars SEP 2024 (Values in Cr)
Revenue 4.80
Operating Expense 5.55
Net Profit -0.31
Net Profit Margin (%) -6.45
Earnings Per Share (EPS) -0.69
EBITDA 0.05
Effective Tax Rate (%) 20.51
Particulars JUN 2024 (Values in Cr)
Revenue 8.85
Operating Expense 8.76
Net Profit 0.30
Net Profit Margin (%) 3.38
Earnings Per Share (EPS) 0.67
EBITDA 0.82
Effective Tax Rate (%) 16.66
Particulars MAR 2025 (Values in Cr)
Revenue 25.43
Operating Expense 27.03
Net Profit -1.03
Net Profit Margin (%) -4.05
Earnings Per Share (EPS) -2.31
EBITDA 0.32
Effective Tax Rate (%) 27.14
Particulars MAR 2024 (Values in Cr)
Revenue 29.90
Operating Expense 32.44
Net Profit -1.36
Net Profit Margin (%) -4.54
Earnings Per Share (EPS) -3.07
EBITDA -0.01
Effective Tax Rate (%) 28.64
Particulars MAR 2023 (Values in Cr)
Revenue 38.76
Operating Expense 37.72
Net Profit 0.65
Net Profit Margin (%) 1.67
Earnings Per Share (EPS) 1.47
EBITDA 2.57
Effective Tax Rate (%) 25.84
Particulars MAR 2022 (Values in Cr)
Revenue 53.56
Operating Expense 51.40
Net Profit 1.88
Net Profit Margin (%) 3.51
Earnings Per Share (EPS) 4.24
EBITDA 4.00
Effective Tax Rate (%) 28.24
Particulars MAR 2021 (Values in Cr)
Revenue 34.81
Operating Expense 33.16
Net Profit 1.08
Net Profit Margin (%) 3.10
Earnings Per Share (EPS) 2.44
EBITDA 2.99
Effective Tax Rate (%) 35.11
Particulars MAR 2025 (Values in Cr)
Book Value / Share 28.51
ROE % -7.81
ROCE % -3.03
Total Debt to Total Equity 0.57
EBITDA Margin 1.26
Particulars MAR 2024 (Values in Cr)
Book Value / Share 30.87
ROE % -9.46
ROCE % -4.43
Total Debt to Total Equity 0.63
EBITDA Margin -0.03
Particulars MAR 2023 (Values in Cr)
Book Value / Share 33.87
ROE % 3.86
ROCE % 6.64
Total Debt to Total Equity 0.51
EBITDA Margin 6.24
Particulars MAR 2022 (Values in Cr)
Book Value / Share 32.60
ROE % 10.65
ROCE % 13.09
Total Debt to Total Equity 0.37
EBITDA Margin 6.29
Particulars MAR 2021 (Values in Cr)
Book Value / Share 28.29
ROE % 9.00
ROCE % 13.45
Total Debt to Total Equity 0.30
EBITDA Margin 8.59
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 23.29
Total Liabilities 23.29
Total Equity 12.66
Share Outstanding 4440568
Price to Book Ratio 1.19
Return on Assets (%) -4.41
Return on Capital (%) -5.57
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 25.95
Total Liabilities 25.95
Total Equity 13.70
Share Outstanding 4440568
Price to Book Ratio 1.36
Return on Assets (%) -5.25
Return on Capital (%) -5.94
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.19
Total Assets 32.45
Total Liabilities 32.45
Total Equity 15.03
Share Outstanding 4440568
Price to Book Ratio 1.08
Return on Assets (%) 2.01
Return on Capital (%) 2.75
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.87
Total Assets 28.96
Total Liabilities 28.96
Total Equity 14.47
Share Outstanding 4440568
Price to Book Ratio 1.23
Return on Assets (%) 6.49
Return on Capital (%) 9.02
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.85
Total Assets 26.04
Total Liabilities 26.04
Total Equity 12.56
Share Outstanding 4440568
Price to Book Ratio 0.84
Return on Assets (%) 4.16
Return on Capital (%) 6.69
Particulars MAR 2025 (Values in Cr)
Net Income -1.40
Cash from Operations 2.65
Cash from Investing 1.52
Cash from Financing -4.21
Net change in Cash 0.00
Free Cash Flow 2.90
Particulars MAR 2024 (Values in Cr)
Net Income -1.91
Cash from Operations 0.34
Cash from Investing 0.40
Cash from Financing -0.40
Net change in Cash -0.02
Free Cash Flow 1.29
Particulars MAR 2023 (Values in Cr)
Net Income 0.88
Cash from Operations -1.30
Cash from Investing -0.07
Cash from Financing 1.60
Net change in Cash -0.17
Free Cash Flow -0.40
Particulars MAR 2022 (Values in Cr)
Net Income 2.62
Cash from Operations -0.58
Cash from Investing -4.96
Cash from Financing 2.27
Net change in Cash -3.95
Free Cash Flow 0.57
Particulars MAR 2021 (Values in Cr)
Net Income 1.67
Cash from Operations 5.32
Cash from Investing -2.16
Cash from Financing -0.33
Net change in Cash 2.35
Free Cash Flow 7.12
Company Name Price P/E P/B Market Cap 52 Week Low/High
ATUL LTD 6395.80 37.67 3.36 18830.36 4882.00 / 8165.25
BASF INDIA LTD 4586.15 50.95 5.46 19851.44 4076.75 / 8748.10
ORIENTAL AROMATICS LTD 336.95 47.52 1.71 1133.96 252.40 / 656.00
DEEPAK FERTILIZERS & PETR 1491.00 19.18 3.01 18822.06 888.25 / 1776.95
DEEPAK NITRITE LTD 1814.30 40.77 4.59 24745.79 1780.50 / 3094.70
Company Name Price P/E P/B Market Cap 52 Week Low/High
ADVANCE PETROCHEMICALS LTD. 169.10 50.63 3.85 15.22 169.10 / 330.00
ATUL LTD 6395.80 42.33 3.40 18830.36 4882.00 / 8165.25
BASF INDIA LTD 4586.15 48.23 5.42 19851.44 4076.75 / 8748.10
ORIENTAL AROMATICS LTD 336.95 27.71 1.67 1133.96 252.40 / 656.00

LINK PHARMA CHEM LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
35.89 -0.16 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 35.60
  • 26 Days 36.00
  • 10 Days 35.70
  • 50 Days 36.10
  • 12 Days 35.80
  • 100 Days 36.50
  • 20 Days 35.90
  • 200 Days 37.80
34.44 PIVOT

First Support

34.28

First Resistance

34.52

Second Support

34.20

Second Resistance

34.68

Third Support

34.04

Third Resistance

34.76

RSI

43.70

ADX

25.90

MACD

-0.23

Williams % R

-71.91

Commodity Channel Index (CCI)

-110.80

Date

2025-08-19

Week

427.00

Same Day

202.00

Month

1028.00

1 Year

0.84

3 Year

0.45

Over 1 Month

-1.82%

down

Over 1 Year

-18.71%

down

Over 3 Months

-3.18%

down

Over 3 Years

-3.59%

down

Over 6 Months

-4.92%

down

Over 5 Years

9.27%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

LINK PHARMA CHEM LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

LINK PHARMA CHEM LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

LINK PHARMA CHEM LTD. Share Price

Link Pharma Chem Ltd (LPCL) is a mid-size leading chemical manufacturing company, incorporated in the year 1986. The Company operate in the small-scale sector to manufacture 300 tpa of thionil chloride(TC). The Company increased its capacity to 1500 tpa in 1989 to meet the growing demand. It undertook a further expansion in 1993 with assistance from SIDBI to increase capacity to 2100 tpa, which was completed in 1994.

The Company is engaged in manufacturing and exporting multi range intermediates for pharmaceutical, agro industries and specialty chemicals. It is engaged in custom synthesis / contract manufacturing for multistage synthesis for small, medium, large companies as well. The Company's strength lies in carrying out very critical corrosive reactions involving chemicals like Chlorine, Oleum, Chlorosulphonic Acid, Sulphuric Acid, Sulphur Chlorides etc. and also to control the laid down environmental needs. It is equipped with adequate glass lined & S. S. reactor capacities aided by all sorts of utilities and supporting accessories. The services offered are contract manufacturing facilities; development of multi step pathways for organic synthesis and refinement and optimization of existing synthetic methods.

A partnership firm (cap.: 1080 tpa) manufacturing chlorinated paraffin (CP) was merged with LPCL in Apr.'94. This formed the present unit, 'Link Pharma Chem'. It modernized and expanded its TC capacity to 3300 tpa, expanded its product range to include CP 70 (450 tpa), and integrated forward to manufacture dinitro ortho-toluamide (DOT, 450 tpa).

While TC is used as an intermediate in the production of pesticides, pharmaceuticals and dyestuffs, DOT is primarily used as an additive in poultry feed, and CP finds application mainly as a filler material in paints, PVC products, lube oils, etc. LPCL entered into a buy-back arrangement with Gharda Chemicals, a leading manufacturer of pesticides, for over 35% of its capacity of TC.

In 1995-96 Company expanded the project for manufacture of Thionyl Chloride and intermediates from 2100 TPA to 3300 TPA.

Parent organization Indian Private
NSE symbol [-]
Founded 1984
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Link Pharma Chem Ltd?

Answer Field

Link Pharma Chem Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 35.89 as on Aug 22 2025 03:23 PM.

What is the Market Cap of Link Pharma Chem Ltd Share?

Answer Field

The market cap of Link Pharma Chem Ltd for NSE ₹ 0.00 & for BSE ₹ 15.90 as on Aug 22 2025 03:23 PM.

What is the 52 Week High and Low of Link Pharma Chem Ltd?

Answer Field

The 52 Week High and Low of Link Pharma Chem Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 50.90 and ₹ 28.21.

What is 1 year return for Link Pharma Chem Ltd?

Answer Field

The 1 year returns on the stock has been -17.41%.

What is the P/E Ratio of Link Pharma Chem Ltd Share?

Answer Field

As on Aug 22 2025 03:23 PM the price-to-earnings (PE) ratio for Link Pharma Chem Ltd share is -17.28.

What is the PB ratio of Link Pharma Chem Ltd Share?

Answer Field

As on Aug 22 2025 03:23 PM, the price-to-book (PB) ratio for Link Pharma Chem Ltd share is 28.51.

How to Buy Link Pharma Chem Ltd Share?

Answer Field

You can trade in Link Pharma Chem Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Link Pharma Chem Ltd Share on Bajaj Broking App?

Answer Field

To buy Link Pharma Chem Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Link Pharma Chem Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91